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Psychostimulant drugs of abuse increase dendritic spine density in reward centers
of the brain. However, little is known about their effects in the hippocampus, where
activity-dependent changes in the density of dendritic spine are associated with
learning and memory. Recent reports suggest that Cdk5 plays an important role
in drug addiction, but its role in psychostimulant’s effects on dendritic spines in
hippocampus remain unknown. We used in vivo and in vitro approaches to demonstrate
that amphetamine increases dendritic spine density in pyramidal neurons of the
hippocampus. Primary cultures and organotypic slice cultures were used for cellular,
molecular, pharmacological and biochemical analyses of the role of Cdk5/p25 in
amphetamine-induced dendritic spine formation. Amphetamine (two-injection protocol)
increased dendritic spine density in hippocampal neurons of thy1-green fluorescent
protein (GFP) mice, as well as in hippocampal cultured neurons and organotypic slice
cultures. Either genetic or pharmacological inhibition of Cdk5 activity prevented the
amphetamine–induced increase in dendritic spine density. Amphetamine also increased
spine density in neurons overexpressing the strong Cdk5 activator p25. Finally, inhibition
of calpain, the protease necessary for the conversion of p35 to p25, prevented
amphetamine’s effect on dendritic spine density. We demonstrate, for the first time,
that amphetamine increases the density of dendritic spine in hippocampal pyramidal
neurons in vivo and in vitro. Moreover, we show that the Cdk5/p25 signaling and calpain
activity are both necessary for the effect of amphetamine on dendritic spine density.
The identification of molecular mechanisms underlying psychostimulant effects provides
novel and promising therapeutic approaches for the treatment of drug addiction.
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INTRODUCTION
Changes in behavior that occur as a function of experience, like environmental enrichment
(Engmann et al., 2015), drug addition (Robinson and Kolb, 1997; Rasakham et al., 2014),
injuries (Tseng and Hu, 1996; Chen et al., 2003) and throughout aging (Scheibel et al., 1975;
Wang et al., 2009), have their basis in the reorganization of excitatory synaptic connections,
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also known as structural plasticity of dendritic spines. Structural
plasticity involves a variety of proteins controlling the
organization of the actin cytoskeleton (Schubert and Dotti,
2007; Cingolani and Goda, 2008) and changes in dendritic spine
shape, size and number are determined by local actin dynamics
(Fischer et al., 2000; Tada and Sheng, 2006; Lai and Ip, 2013).
Activity-dependent dynamic changes in spines of hippocampal
pyramidal neurons are essential for learning and memory (Yuste
and Bonhoeffer, 2001; Kasai et al., 2003).
The Cdk5/p35 signaling complex has been involved in
multiple processes during typical brain development, including
neuronal migration and the formation of axons and dendrites
(Nikolic et al., 1996; Chae et al., 1997; Paglini et al., 1998,
2001; Kwon et al., 1999; Smith and Tsai, 2002), as well as
in associative learning and memory in adult rodents (Fischer
et al., 2002, 2005; Angelo et al., 2006; Bignante et al.,
2008). On the other hand, Cdk5 plays a critical role in
the pathophysiology of several neurodegenerative disorders.
Deregulation of Cdk5 results in neuronal loss in Parkinson’s,
Alzheimer’s and Huntington’s diseases (Cheung and Ip, 2012;
Shah and Lahiri, 2014), which underscores the importance of
the complex regulation of Cdk5 activity necessary to maintain
its activity within physiological levels. Cdk5 kinase activity is
regulated in many different ways. The main regulators of its
kinase activity are the activators p35 and p39, which are highly
expressed in adult brain (Tsai et al., 1994; Tang et al., 1995).
Other Cdk5 regulators in postmitotic neurons are the Cyclin
family proteins, such as Cyclin D1, Cyclin E and Cyclin I (De
Falco et al., 2004; Brinkkoetter et al., 2010; Odajima et al.,
2011). In addition, glutathione-S-transferase P (GSTP1) binds
to Cdk5 and modulates its activity in neurons (Sun et al.,
2011). Furthermore, Cdk5 can be regulated by posttraslational
modifications, such as phosphorylation and S-nitrosylation
(reviewed in Shah and Lahiri, 2014). The N-terminal domain
of the Cdk5 activator p35 is cleaved by the Ca+-dependent
cysteine protease calpain, which generates p25, a C-terminal
truncation peptide that contains all necessary elements for
Cdk5 activation (Kusakawa et al., 2000; Lee et al., 2000; Nath
et al., 2000; Dhavan and Tsai, 2001; Patzke et al., 2003). Since
p25 is resistant to ubiquitin-mediated proteolysis, it substantially
extends the activation period of Cdk5 (Patrick et al., 1999).
Relevant to our studies, transient expression of p25 increased
the number of synapses and dendritic spine density, enhancing
hippocampal LTP and facilitating learning and memory (Fischer
et al., 2005).
Notably, exposure to either amphetamine or cocaine increases
the dendritic spine density in reward centers of the brain,
suggesting that the molecular mechanisms involved in other
forms of synaptic plasticity are hijacked by drugs of abuse (Berke
and Hyman, 2000; Hyman and Malenka, 2001; Kolb et al., 2003;
Robinson and Kolb, 2004). Although the dopaminergic system is
the focus of intense research of motivational and reward-related
learning (Li et al., 2003; Chen et al., 2010), the neurobiological
basis of natural reward learning and memory cannot be fully
explained without the contribution of the hippocampus, a brain
area that sends a main output to the dopaminergic reward
system. In addition, the hippocampus is a principal site of
activity-dependent process during learning and memory (Grace
et al., 2007). Little is known, however, about the effects of drugs
of abuse on hippocampus.
Interestingly, recent reports have demonstrated that
Cdk5 participates in addiction to drugs of abuse (Benavides
and Bibb, 2004; Mlewski et al., 2008, 2016). The inhibition
of Cdk5 activity with roscovitine decreases cocaine-induced
dendritic spine formation in the nucleus accumbens, suggesting
that Cdk5 is involved in cocaine-induced dendritic spine
morphogenesis (Norrholm et al., 2003). Nevertheless, the
detailed mechanism/s by which this or other signaling
modules participate in dendritic spine formation induced
by psychostimulants in the hippocampus or other brain areas
remains to be determined.
In the present study, we demonstrate that amphetamine
increases dendritic spine density in pyramidal neurons of the
hippocampus. Using a two-amphetamine-injections protocol in
a novel context, we observe an increase in dendritic spines
density in hippocampal CA1 pyramidal neurons of young mice.
In addition, amphetamine increases spine density in primary
hippocampal cultures and organotypic slice cultures. Lastly, we
provide evidence of the necessity of the Cdk5/p25 signaling
complex and of calpain activity for amphetamine to increase
spine density.
MATERIALS AND METHODS
Animals
Mice harboring the thy1-green fluorescent protein (GFP)
transgene (Feng et al., 2000) were generated by breeding
male heterozygous B6.Cg-Tg(Thy1-EGFP)MJrs/J mice (Jackson
Laboratory, Bar Harbor, ME, USA) with female C57BL/6J
wild type mice. Animals were weaned at postnatal day (P)
21 and housed 4–5 per cage under a 12 h light/12 h
dark cycle at constant temperature (22◦C) with free access
to food and water. All experiments were performed with
P33–40 mice in an isolated behavioral room during the light
cycle, between 10:00 AM and 3:00 PM. Embryonic Wistar
rats were used for in vitro primary cultures. All animals used
in the present study were born and reared at the vivarium
of the INIMEC-CONICET-UNC (Cordoba, Argentina). All
procedures and care performed in the animals were approved
by National Department of Animal Care and Health (SENASA,
Argentina) and were in accordance with National Institute of
Health general guidelines for the Care and Use of Laboratory
Animals. Best efforts were made to reduce the number of
animals used and to minimize their suffering. The experimental
protocol was reviewed and approved by Institutional Animal
Care and Use Committee (CICUAL protocol No. 2016-0001)
and complied with the regulations of the Guide for Care
and Use of Laboratory Animals (National-Research-Council,
1996).
Drugs
D-Amphetamine (Sigma-Aldrich, St. Louis, MO, USA and
Parafarm, Buenos Aires, Argentina), N-Acetyl-L-leucyl-L-
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norleucinal (ALLN; Sigma-Aldrich, St. Louis, MO, USA) and
roscovitine (Calbiochem, San Diego, CA, USA) were used in this
study.
Drug Administration
We performed the two-injection protocol of sensitization (TIPS),
which consist of two phases: in the first day (phase 1)
mice were treated with either an i.p. injection of 4 mg/kg
amphetamine or an equivalent volume of saline solution
(sal, 0.9% NaCl) and immediately placed in a novel context
(open field) for 1 h. After 1 day without receiving any
treatment, mice received either amphetamine or sal, and
were placed for 1 h in the novel context (phase 2). Male
mice were randomly divided into four treatment groups:
(1) receiving two vehicle saline injections (sal/sal); (2) receiving
saline first and then amphetamine injections (sal/amph);
(3) receiving amphetamine first and then saline injections
(amph/sal); and (4) receiving two amphetamine injections
(amph/amph).
Brain Fixation
Four hours after drug treatments, mice were anesthetized with an
i.p. injection of chloral hydrate (0.1 mL/100 g) and transcardially
perfused as described (Krapacher et al., 2010). The brains were
cut coronally at 100µmwith a freezingmicrotome (Reicher-Jung
Hn40, Leica Microsystems, Wetzlar, Germany) and the collected
sections were mounted with Vectashield (Vector Laboratories,
Burlingame, CA, USA).
Primary Cultures of Dissociated Neurons
Cultures of dissociated hippocampal pyramidal cells from
embryonic rats were prepared as described (Kunda et al., 2001).
Neurons at 17–19 days in vitro (DIV) with long axons and
well-developed dendritic arbors were used for all experiments.
Organotypic Slice Cultures
Hippocampal slice cultures were prepared from P7 to P10Wistar
rats and maintained in vitro as described (Stoppini et al.,
1991; Tyler and Pozzo-Miller, 2001). Briefly, rats were
quickly decapitated and their brains aseptically dissected
and immersed in ice-cold dissecting solution, consisting
of Hanks’ Balanced Salt Solution (HBSS; ThermoFisher
Scientific, Waltham, MA, USA) supplemented with glucose
(41.55 mM) and antibiotics (1:100; penicillin/streptomycin).
Hippocampi were then dissected and transversely sectioned
into 400∼500 µm slices using a custom-made tissue slicer
(Katz, 1987) strung with 20 µm-thick tungsten wire (California
Fine Wire Company, Grover Beach, CA, USA). Slices were
incubated at 4◦C for 30 min, and then plated on tissue
culture inserts (0.4 µm pore size, Millicell-CM, Millipore
Corporation, Billerica, MA, USA). Culture media contained
Neurobasal-A (ThermoFisher Scientific, Waltham, MA, USA),
heat-inactivated horse serum (20%) and L-glutamine (1 mM;
ThermoFisher Scientific, Waltham, MA, USA). Organotypic
cultures were maintained in incubators at 36◦C, 5% CO2,
98% relative humidity. The concentration of horse serum
in the culture medium was reduced from 20% to 10% at
4 DIV and again reduced to 5% 24 h later. After 24 h in
medium containing 5% horse serum, slices were placed in
serum-free medium (Neurobasal-A plus B-27 supplement,
ThermoFisher Scientific, Waltham, MA, USA) until used for
experiments.
DNA Constructs
The following constructs were used: expression cDNA plasmid
coding for enhanced yellow fluorescent protein (YFP) obtained
from Clontech Inc (Mountain View, CA, USA); expression
cDNA plasmid pcDNA3-dnCDK5was generous gift of Dr. Philip
W. Hinds; plasmid DNA coding for p35-full-length was
generous gift of Dr. Christopher C. J. Miller. To generate
the fusion protein of human p25 with GFP (p25-GFP), a
DNA fragment encoding the p25 sequence was obtained by
PCR using Pfu polymerase (Stratagene Cloning Systems, La
Jolla, CA, USA), with a BamH1 restriction site introduced
into the 5′-end and a SAL site into the 3′-end, and cloned
into the pEGFP-N1 vector (Clontech Inc, Mountain View,
CA, USA). The Cdk5 short hairpin RNA (shRNA) plasmid
was constructed in pSilencer U6 1.0 vector (Ambion Inc,
Austin, TX, USA). 5′-GGG AGATCTGTCTACTCAAAGAA
and 5′-GGG ATT CTG TCA CAG CCG TAA CG were
used as targeting sequences following the procedures described
(Chuang et al., 2005). The DNA fragments containing U6-
Cdk5-sh and U6-control-sh were inserted into pCAG-HcRed
vector under the control of chick actin-minimal (CAG)
promoter; the resulting plasmids were referred to as shCdk5.
Western immunoblots of Cdk5-expressing N2a cells (brain
neuroblastoma) confirmed that shCdk5 reduced Cdk5 protein
levels (data not shown).
Transfection Methods
For primary neuronal cultures, transient transfections were
performed at 16 DIV on 30 mm dishes, using Lipofectamine
2000 (Invitrogen, San Diego, CA, USA) according to the
manufacture’s recommendations. For experiments with
organotypic cultures, slices were biolistically-transfected at
7 DIV, as described (Alonso et al., 2004). Briefly, prior to
transfection, a mixture of penicillin/streptomycin/amphotericin
B (ThermoFisher Scientific, Waltham, MA, USA) was added
to the culture media in order to prevent contamination
during biolistic transfection; this mixture was removed after
24 h. The plasmid (cDNAs of interest) were precipitated
onto 25 mg of 1.6 µm-diameter colloidal gold at a ratio of
63.5 µg of YFP to 113.5 µg of interest plasmid and then
coated onto Tefzel tubing. The success rate of co-transfection
of the same neuron with two cDNA plasmids using the
gene-gun has been demonstrated to be >90% (Boda et al.,
2004; Moore et al., 2007), significantly reducing the likelihood
of occurrence of YFP-positive and dnCDK5/p35/p25-negative
neurons.
Culture Fixation
Fifteen hours after transfection, hippocampal slice cultures
were exposed to amphetamine (50 µM) and/or roscovitine
(10 µM) for 48 h and then were fixed by immersion in
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4% paraformaldehyde in 100 mM phosphate buffer (overnight
at 4◦C), and washed in PBS. Filter membranes around each
slice were trimmed, and each slice was individually mounted
on glass slides and cover slipped using Vectashield (Vector
Laboratories, Burlingame, CA, USA). Cultured hippocampal
neurons received the same treatment and then coverslips with
neurons were fixed for 20 min in 4% paraformaldehyde in
100 mM phosphate buffer at room temperature and mounted
on glass slides using FluorSave (Calbiochemr Merck KGaA,
Darmstadt, Germany).
Laser-Scanning Confocal Microscopy
High-resolution images of tertiary and quaternary branches
of apical dendrites of pyramidal neurons, displaying either
GFP or YFP fluorescence throughout the whole dendritic
tree, were acquired in Fluoview FV300 and FV1000 laser-
scanning confocal microscopes (Olympus, Tokyo, Japan) using
oil immersion 40× (NA 1.4) and 63× (NA 1.4) objectives
(PlanApo, Olympus) and 3× digital zoom. GFP and YFP were
excited using an Ar laser (488 nm), and detected using standard
FITC filters. Series of optical sections were acquired in the
z-axis at 0.12 µm intervals through individual apical dendritic
branches.
Quantitative Analyses of Dendritic Spine
Density and Morphology
Small protrusions that extended≤3µm from the parent dendrite
were identified as dendritic spine. Spines were counted in
maximum-intensity projections of the z-stacks using ImageJ
software (National Institute of Health, Bethesda, MD, USA),
only if they appeared continuous with the parent dendrite.
Spine density was calculated by quantifying the number of
spines per dendritic segment, and normalized to 10 µm of
dendrite length. The classification of morphological spine types
was performed as described (Tyler and Pozzo-Miller, 2003).
Spine types were grouped as immature-shaped thin (type-III)
spines, mature-shaped spines, which included type-I (stubby)
and type II (mushroom) spines, according published criteria
(Boda et al., 2004). Images of pyramidal neurons in primary
cultures were deconvolved in Fiji (Schindelin et al., 2012),
followed by NeuronStudio processing in order to categorize
dendritic spines into three morphological types based on their
length and the dimensions of the spine head and neck: stubby,
mushroom and thin (Rodriguez et al., 2008).
The total length of secondary and tertiary apical dendrites
analyzed for Figure 1 was: (i) sal/sal: 1244.58 µm from
20 dendritic segments of 9 cells; (ii) sal/amph: 1041.50 µm from
18 dendritic segments of 8 cells; (iii) amph/sal: 1078.29 µm
from 20 dendritic segments of 8 cells; (iv) amph/amph: 1321.83
µm from 23 dendritic segments of 9 cells. For Figure 2,
dissociated culture: (i) vehicle: 1432.03 µm from 34 dendritic
segments of 10 cells; (ii) amph: 2084.79 µm from 40 dendritic
segments of 14 cells; organotypic culture: (iii) vehicle: 840.93 µm
from 26 dendritic segments of 12 cells; (iv) amph: 1204.28 µm
from 34 dendritic segments of 15 cells. For Figure 3B: (i) eYFP-
vehicle: 840.93 µm from 26 dendritic segments of 13 cells;
(ii) dnCdk5-vehicle: 1528.945 µm from 34 dendritic segments
of 14 cells; (iii) rosco-vehicle: 1227.58 µm from 16 dendritic
segments of 6 cells; (iv) shCd5-vehicle: 689.22 µm from
18 dendritic segments of 3 cells; (v) eYFP-amph: 1204.28
µm from 34 dendritic segments of 12 cells; (vi) dnCdk5-
amph: 1433.04 µm from 31 dendritic segments of 16 cells;
(vii) rosco-amph: 1784.51 µm from 27 dendritic segments
of 9 cells; (viii) shCd5-amph: 427.9 µm from 18 dendritic
segments of 4 cells. For Figure 3E; (ix) eYFP-vehicle: 840.93
µm from 26 dendritic segments of 13 cells; (x) amph-
vehicle: 1528.945 µm from 12 dendritic segments of 12 cells;
(xi) p25-vehicle: 1241.19 µm from 26 dendritic segments
of 7 cells; (xii) p25-amph: 1918.05 µm from 43 dendritic
segments of 13 cells; (xiii) p35-vehicle: 581.81 µm from
13 dendritic segments of 8 cells; (xiv) p35-amph: 855.81 µm
from 21 dendritic segments of 13 cells. For Figure 4B: (i)
vehicle: 642.49 µm from 11 dendritic segments of 3 cells;
(ii) 15 min amph: 717.48 µm from 11 dendritic segments
of 3 cells; (iii) 30 min amph: 474.65 µm from six dendritic
segments of 3 cells; (iv) 60 min amph: 749.2 µm from
20 dendritic segments of 4 cells. For Figure 4E; (v) vehicle-
control: 792 µm from 19 dendritic segments of 7 cells; (vi)
vehicle-ALLN: 304.6 µm from 8 dendritic segments of 4 cells;
(vii) amph-control: 750µm from 20 dendritic segments of 7 cells;
(viii) amph-ALLN: 350.89 µm from 9 dendritic segments of
6 cells.
Western Immunoblots
Crude synaptosomal fractions were obtained as described
(Mlewski et al., 2008). All samples were valued for protein
concentration (DC Protein Assay Kit, Bio-Rad Laboratory,
Hercules, CA, USA) and equal protein amounts (25 µg)
were separated into 10% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis and then transferred to Nitrocellulose
membranes (Bio-Rad Laboratory, Hercules, CA, USA) as
previously described (Krapacher et al., 2010). Membranes were
incubated overnight at 4◦C with their primary antibodies diluted
in 1% skim milk in TBST. The antibodies used were anti-α-
tubulin (1:3000, DM1A; Sigma-Aldrich, St. Louis, MO, USA)
and anti-spectrin (1:1000, Millipore Corporation, Billerica, MA,
USA). Membranes were then washed three times in TBST
and incubated with a Licor secondary antibody (1:15,000,
IRDyer 800CW LI-COR Biosciences, Lincoln, NE, USA) or
a horseradish peroxidase–conjugated antibody (1:2000; Jackson
ImmunoResearch Laboratories, West Grove, PA, USA) for 1 h at
room temperature. After two washes with TBST and two washes
with TBS, bands were visualized using Odissey scanner (LI-COR
Biosciences, Lincoln, NE, USA) or a chemiluminescence
detection kit (ECL; Amersham Life Science, Buckinghamshire,
England) according to the primary antibody used.
Statistical Analyses
All data were analyzed using Statistica 7.0 (Statsoft, Inc., Tulsa,
OK, USA). Statistical analyses were performed using ANOVAs.
Significant main effects were further analyzed through Fisher’s
LSD post hoc test (Fisher’s least significance difference test with a
Type I error set at 0.05).
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FIGURE 1 | In vivo exposure to amphetamine increased dendritic spine density in hippocampal CA1 pyramidal neurons. (A) Representative image of the CA1 region
of a thy1-green fluorescent protein (GFP) mouse showing GFP-expressing pyramidal neurons. White box indicates the region where dendritic segments were imaged
at high magnification; scale bar = 20 µm. (B) Representative dendritic segments of CA1 pyramidal neurons of thy1-GFP mice; scale bar = 5 µm. (C) Dendritic spine
density expressed as the number of spines normalized to 10 µm of dendritic length; data are mean ± SEM. ∗ Indicates statistically significant differences vs. sal/sal,
#vs. all treatment groups (one way ANOVA, ∗p = 0.0001). (D) Density of the three different morphological spine types (stubby, mushroom and thin). ∗ Indicates
statistically significant differences (one way ANOVA, ∗p = 0.001). N = 4 mice; n = 3 dendritic segments per mouse.
RESULTS
In Vivo Administration of Amphetamine
Increases Dendritic Spine Density in
CA1 Hippocampal Pyramidal Neurons
We have previously shown that adolescent rats develop
and express locomotor sensitization after an amphetamine
two-injection protocol (4 mg/kg) when they were trained and
evaluated in a novel environment (Mlewski et al., 2016). To
test if this exposure to amphetamine affects dendritic spines
in hippocampal neurons, we used the same protocol in male
P35–40 thy1-GFP transgenic mice (line M), which express GFP
in pyramidal neurons in a Golgi-type fashion (Feng et al., 2000;
Figures 1A,B).
Amphetamine induced a significant increase of the density
of spine in apical dendrites of CA1 pyramidal neurons in
all groups (sal/amph, amph/sal and amph/amph) compared to
sal/sal controls. ANOVA revealed a significant main effect of
amphetamine (one-way ANOVA F(3,30) = 10.304, ∗p < 0.0001),
indicating that mice treated with amphetamine have higher
dendritic spine density than sal/sal controls (Figure 1C).
Amphetamine also modulated the morphology of individual
spines, increasing the density of stubby spines (one-way ANOVA
F(3,30) = 7.3287, ∗p = 0.001; Figure 1D).
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FIGURE 2 | In vitro amphetamine exposure increased dendritic spine density in hippocampal neurons maintained in either dissociated or organotypic slice culture.
(A) Representative images of hippocampal pyramidal neurons maintained in dissociated cultures or organotypic slice cultures (scale bar = 20 µm).
(B) Representative examples of secondary or tertiary dendritic segments of cultured pyramidal neurons (17–19 DIV) expressing yellow fluorescent protein (YFP) and
exposed to 50 µM amphetamine (amph) or vehicle for 48 h (scale bar = 5 µm). (C) Dendritic spine density (one-way ANOVA, ∗p = 0.001). (D) Representative
maximum-intensity projections of confocal z-stacks of dendritic segments of YFP-expressing CA1 pyramidal neurons in slice culture (10 DIV), exposed to either
50 µM amphetamine or vehicle for 48 h (scale bar = 5 µm). (E) Dendritic spine density (one-way ANOVA, ∗p = 0.005). (F) Density of three different morphological
spine types (stubby, mushroom and thin; one-way ANOVA, ∗p = 0.05). Samples of dissociated cultures (four different cultures): vehicle n = 10 neurons, amph n = 14.
Samples of organotypic slice cultures (three different cultures): vehicle n = 13, amph n = 13.
These results demonstrate that amphetamine, administrated
in a two-injection protocol known to trigger locomotor
sensitization, increases dendritic spine density in CA1 pyramidal
neurons favoring the mature stubby type.
In Vitro Administration of Amphetamine
Increases Dendritic Spine Density in
Hippocampal Pyramidal Neurons
To develop an in vitro assay amenable for testing molecular
mechanisms, we exposed YFP-expressing cultured hippocampal
neurons to amphetamine (50 µM) for 48 h (Figure 2A).
Consistent with in vivo observations, amphetamine significantly
increased spine density in YFP-expressing neurons maintained
in primary culture (Figures 2B,C; one-way ANOVA
F(1,22) = 16.576, ∗p = 0.001). In addition, amphetamine (50 µM)
induced a significant increase of spine density in YFP-expressing
CA1 pyramidal neurons maintained in hippocampal slice
cultures (Figures 2A,D,E; one way ANOVA F(1,26) = 9.9457,
∗p = 0.005). Similar to its effects in vivo, amphetamine increased
the density of mature stubby spines (one way ANOVA,
F(1,26) = 5.5401, ∗p = 0.05), and also of the mushroom type (one
way ANOVA, F(1,26) = 4.7140, ∗p = 0.05; Figure 2F).
Together with the observations in vivo, these results in
two different in vitro preparations provide strong evidence of
amphetamine-induced structural plasticity in pyramidal neurons
of the hippocampus.
Cdk5 Activity Is Necessary for
Amphetamine to Increase Dendritic Spine
Density in Hippocampal Pyramidal
Neurons
Considering that Cdk5 plays a role in cocaine-induced dendritic
spine formation in the nucleus accumbens (Norrholm et al.,
2003), we tested whether it is also involved in the effects
of amphetamine on CA1 hippocampal pyramidal neurons.
To this end, we used three strategies: (1) slice cultures were
biolistically co-transfected with YFP and dominant negative
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FIGURE 3 | Cdk5 knockdown or pharmacological inhibition prevent amphetamine-evoked increase in dendritic spine density. (A) Representative maximum-intensity
projections of confocal z-stacks of dendritic segments of YFP-expressing CA1 pyramidal neurons in slice culture (10 DIV), biolistically co-transfected with either
dnCdk5 or a short hairpin RNA (shRNA) against Cdk5, and exposed to 50 µM amphetamine (amph), vehicle, or roscovitine (10 µM) for 48 h (scale bar = 5 µm).
(B) Dendritic spine density in each condition (two-way ANOVA, ∗p = 0.01). (C) Density of mushroom spine type (two-way ANOVA, ∗p = 0.0001). (D) Representative
maximum-intensity projections of confocal z-stacks of dendritic segments of CA1 pyramidal neurons in slice culture (10 DIV), biolistically co-transfected with either
p35 or p25, and exposed to 50 µM amphetamine (amph) or vehicle for 48 h (scale bar = 5 µm). (E) Dendritic spine density for each condition (two-way ANOVA,
∗p = 0.005). (F) Density of three different morphological spine types (stubby, mushroom and thin; one-way ANOVA, ∗p = 0.01 and ∗p = 0.05 respectively). N = an
average of nine neurons for each condition from three to eight slices of three different cultures.
Cdk5 (dnCdk5), which abolishes endogenous Cdk5 activation
by p35/p25 (Tsai et al., 1994); (2) pharmacological inhibition
of Cdk5 kinase activity with the specific inhibitor roscovitine;
and (3) slice cultures were biolistically co-transfected with YFP
and a Cdk5 short harping interfering RNA (shCdk5) to suppress
Cdk5 expression.
Expression of dnCdk5, shRNA-mediated Cdk5 knockdown,
and pharmacological Cdk5 inhibition with roscovitine all
prevented the increase in spine density induced by amphetamine
(Figures 3A,B). In addition, all three Cdk5 manipulations
blocked the increase in the density of mushroom spines
induced by amphetamine (two-way ANOVA F(3,68) = 7.47556
∗p = 0.0001; Figure 3C). None of these Cdk5 manipulations by
themselves affected dendritic spine density or morphology (two-
way ANOVA F(3,68) = 3.6015, ∗p = 0.01; Figures 3A,B). These
results demonstrate that amphetamine’s effects on dendritic
spines require intact Cdk5 activity.
Cdk5 activity is induced by the interaction with a
regulatory subunit, either p35 or p25 (proteolytic fragment
of p35; Tsai et al., 1994; Tang et al., 1995). In addition,
the level of p35 is the rate-limiting factor for the activity
of Cdk5 (Takahashi et al., 2005). To examine the role of
p35 and p25 in the amphetamine effect on spine density,
CA1 pyramidal neurons in slice cultures were biolistically
co-transfected with YFP and either p35 or p25. Overexpression
of p35 prevented the increase in spine density induced by
amphetamine. In contrast, p25-expressing neurons exposed
to amphetamine showed the typical increase in spine
density (Figures 3D,E; two-way ANOVA F(2,60) = 3.8051
∗p = 0.005). In addition, p25-expressing neurons exposed to
amphetamine showed higher densities of mature mushroom
spine as well as immature thin spines (Figure 3F; one-way
ANOVA, F(1,18) = 8.1234 ∗p = 0.01 and F(1,18) = 5.7472
∗p = 0.05 respectively).
Together, these results demonstrate that amphetamine’s effect
on spine density requires proper levels of p35 to regulate
Cdk5 activity, and that overexpression of p25 does not affect the
increase of dendritic spine density induced by amphetamine.
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FIGURE 4 | Calpain activity is necessary for amphetamine to increase dendritic spine density in hippocampal pyramidal neurons. (A) Representative dendritic
segments of cultured pyramidal neurons (17–19 DIV) expressing YFP and exposed to either vehicle or amphetamine 50 µM (amph) for 15, 30 and 60 min (scale
bar = 5 µm). (B) Dendritic spine density (one-way ANOVA, ∗p = 0.05). (C) Representative Western immunoblot showing that amphetamine increases calpain
proteolytic activity. Total homogenate of hippocampal neuronal cultures (17–19 DIV) from control (line 1) or amphetamine-treated for 60 min (line 2) or pretreated with
N-Acetyl-L-leucyl-L-norleucinal (ALLN; 10 µM) for 30 min and then exposed to amphetamine for 60 min (lines 3 and 4) or treated with ALLN alone as a control (line
5). (D) Representative maximum-intensity projections of confocal z-stacks of secondary or tertiary dendritic segments of cultured pyramidal neurons (17–19 DIV)
expressing YFP and exposed to vehicle, 50 µM amph for 60 min, ALLN for 30 min followed by amph for 60 min, or ALLN alone (scale bar = 5 µm). (E) Dendritic
spine density for all treatments (two way ANOVA, ∗p = 0.000001). (F,G) Density of mushroom (mush) (F) and thin (G) spine types (one way ANOVA, ∗p = 0.0001 and
∗p = 0.01, respectively).
Calpain Activity Is Necessary for
Amphetamine-Induced Increase Dendritic
Spine Density in Hippocampal Pyramidal
Neurons
Proteolytic cleavage of p35 by the Ca2+ activated cysteine
protease calpain (Liu X. et al., 2008) results in the formation
of p25, which causes hyperactivation of Cdk5 (Kusakawa et al.,
2000; Lee et al., 2000). Considering that the only way to
generate p25 is by proteolytic cleavage of p35 protein by
calpain (Kusakawa et al., 2000), and that amphetamine increases
intracellular Ca2+ levels (Licata and Pierce, 2003; Gnegy et al.,
2004; Mills et al., 2007), we tested if calpain activity is involved in
amphetamine’s effects on dendritic spine density in hippocampal
neurons.
We first tested if exposure to amphetamine activates calpain
activity. Cell lysates from hippocampal neurons were prepared
60 min after application of amphetamine (50 µM) because
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that is when its effect on dendritic spine density becomes
statistically significant (Figures 4A,B; one way ANOVA,
F(3,24) = 3.5324 ∗p = 0.05). Calpain activity was examined
by Western immunoblots using an antibody that recognizes
well-characterized calpain-specific α-spectrin breakdown
products (α-spectrin-BDP; Zhang et al., 2009; Ma et al.,
2012). A 60 min exposure to amphetamine induced robust
calpain activity (Figure 4C, line 2), an effect blocked by
preincubation with the calpain inhibitor ALLN (Figure 4C, lines
3, 4).
Finally, we tested if inhibition of calpain activity prevents
amphetamine’s effect on spine density. Indeed, the calpain
inhibitor ALLN abolished the increase in spine density observed
60 min after exposure to amphetamine (Figures 4D,E; two way
ANOVA, F(3,57) = 12.18 ∗p = 0.000001). Calpain inhibition also
prevented the amphetamine-induced increase in the densities
of mushroom and thin spines types (Figures 4F,G; one way
ANOVA, F(3,57) = 11.021 ∗p = 0.0001 and F(3,57) = 7.9454
∗p = 0.01, respectively).
Taken altogether, our findings demonstrate that
amphetamine increases dendritic spine density in hippocampal
neurons by triggering the proteolytic cleavage of p35 by calpain,
generating p25 to activate Cdk5.
DISCUSSION
This study provides strong findings and novel insight into the
molecular bases by which amphetamine increases dendritic
spine density in hippocampal neurons. Using thy1-GFP
transgenic mice, we show that amphetamine administrated in
a two-injection protocol increased dendritic spine density in
CA1 pyramidal neurons and shifted the density of morphological
types in favor of mature stubby spines. Using two different
in vitro systems, we also show this effect of amphetamine
requires proteolytic cleavage of p35 by calpain to generate
p25 that in turn activates Cdk5.
A great number of studies into the pathophysiology of
drug abuse have concentrated on the dopaminergic reward
system, valuing the neural changes induced during addiction,
relapse, and abstinence in this natural reward regions (Chen
et al., 2010; Deadwyler, 2010; Collo et al., 2014). Even though
the dopaminergic system is central of intense research of
motivational and reward-related learning, the neurobiological
basis of reward learning and memory are uncompleted without
the contribution of the hippocampus, which sends a main
output to the reward system. Considering that this brain
structure lies upstream of the striatal dopaminergic circuit,
synaptic plasticity within the hippocampus may alter the
transmission of information throughout the brain’s reward
system (Grace et al., 2007). Several studies exhibit that
psychostimulant drugs produce persistent alterations in other
forebrain regions as well, in particular, in the orbital frontal
cortex (Fein et al., 2002; Franklin et al., 2002; Paulus et al.,
2002; Adinoff et al., 2003; Bolla et al., 2003; Matochik et al.,
2003). Moreover, human psychostimulants users, as well as
cocaine-exposed monkeys, show deficits in the execution of
cognitive tasks (Rogers et al., 1999; Ornstein et al., 2000; Jentsch
et al., 2002). Also, studies in rats have shown that chronic
cocaine-treatment produce deficits in discrimination learning
(Schoenbaum et al., 2004). Together, these studies indicate
that psychostimulant drugs also produce lasting alterations in
other brain areas related with higher-order associative learning,
in addition to changes in reward circuit. However, little is
known, about the cellular and molecular mechanisms of the
effects of psychostimulant drugs in the hippocampus. In the
few studies performed in rodents, psychostimulant-induced
structural plasticity in non-reward regions like the hippocampus,
has been studied using long chronic administration regimens
(Rademacher et al., 2006; Shen et al., 2006; Boikess et al.,
2010; Ahn et al., 2013). Here, we show for the first time
that amphetamine administrated in a two-injection protocol
increases dendritic spine density in CA1 pyramidal neurons
of thy1-GFP transgenic mice. Interestingly, the largest effect
was observed in mice that had the first experience with
the drug (group sal-amph or amph/sal), suggesting that the
first exposure to amphetamine is enough to induce structural
plasticity in the hippocampus. Amphetamine also modulated
the morphology of individual spines by increasing the density
of stubby spines. This type of spines is the most abundant
during development and is considered very plastic structures,
strongly coupled to the dendritic shaft (Noguchi et al., 2005;
Schmidt and Eilers, 2009). Interestingly, similar to its effects
in vivo, amphetamine increased the density of stubby spines
and also mushroom type in vitro condition. Taken together,
these data provide strong evidences of amphetamine-induced
structural plasticity in hippocampal pyramidal neurons, both
in vivo and in vitro conditions. The particular morphology of
a dendritic spine may play an important role in determining
its function, a concept that has been extensively reviewed
(Shepherd, 1996; Yuste and Majewska, 2001; Nimchinsky et al.,
2002). Two morphological features of dendritic spines seem
to be critical for their role as biochemical compartments:
the geometrical dimensions of the head and neck, which
affect the diffusion and/or accumulation and retention of
ions and molecules generated by synaptic signaling at the
postsynaptic density (e.g., free ionized Ca2+, activated CaMKII).
In addition, the morphology and size of spines correlate with
the strength of the synapses they bear (Pierce and Lewin,
1994). The spine head volume is directly proportional to the
number of docked vesicles at the active zone of presynaptic
terminals (Harris and Sultan, 1995; Boyer et al., 1998; Schikorski
and Stevens, 1999) and to the number of AMPARs (Nusser
et al., 1998). Moreover, the expression of AMPARs within
individual spines of different morphologies was mapped by
2-photon uncaging of MNI-glutamate, revealing that mushroom
(Type-II) spines show larger AMPAR-mediated responses than
thin (Type-III) spines (Matsuzaki et al., 2001). These studies
provide functional evidence that larger spines represent stronger
synapses, as defined by their expression of AMPARs (Kasai
et al., 2003). The induction of LTP leads to an increase in
spine head size, while long-term depression (LTD) causes
spine shrinkage and retraction, which correlates well with the
synaptic levels of AMPARs observed after the induction of such
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bi-directional synaptic plasticity. Despite the large literature, it
remains unclear to what extent the plasticity of dendritic spines
drives the pathological behavior evident in psychostimulants
addiction.
Previously, we demonstrated that both acute and chronic
amphetamine treatment in vivo induced a significant increase
in Cdk5 activity (Mlewski et al., 2008). Other studies explored
the relationship between the activity of Cdk5 and dendritic
spine maintenance (Fu et al., 2007; Lai et al., 2012). Here, we
show that the expression and activity of Cdk5 is necessary
for amphetamine to modulate dendritic spine density and
their morphology: shRNA-mediated Cdk5 knockdown,
pharmacological inhibition with roscovitine, and suppression
of endogenous Cdk5 activity with a dominant negative mutant,
all completely abolished the amphetamine-induced increase
in spine density in hippocampal CA1 pyramidal neurons
maintained in slice culture. These results are consistent with
previous reports of reduction in cocaine-induced increase
in spine density in the nucleus accumbens by roscovitine
(Norrholm et al., 2003). In addition, dendritic spine density is
lower in hippocampal neurons of the double inducible-p35cKO
and p39KO mice, indicating that Cdk5 activity is necessary
for the maintenance of the density of dendritic spine, at least
in hippocampal neurons in adult naïve mice (Mita et al.,
2016).
Considering that Cdk5 and its activators p35 and p25 have
been involved in the effects of chronic exposures to cocaine (Bibb
et al., 2001), methamphetamine (Chen and Chen, 2005), and
amphetamine (Mlewski et al., 2008), we further investigated the
role of p35 and p25 in amphetamine’s effect on dendritic spine
density in hippocampal CA1 pyramidal neurons. Overexpression
of p25 did not affect the amphetamine-evoked increase in
spine density. This result is in line with the increase in
dendritic spine density and number of synapses in an inducible
transgenic mouse that transiently overexpress p25 in the
hippocampus (Fischer et al., 2005). In contrast, overexpression
of p35 completely abolished the effect of amphetamine on
dendritic spine density. Consistent with this result, it has
been demonstrated that high p35 levels binds microtubules
through its N- terminal domain and removes it from Cdk5,
rendering the kinase inactive (Shah and Lahiri, 2014). In
addition, p35 binding to microtubules promotes microtubule
bundling (He et al., 2008) and their stabilization (Hou et al.,
2007). Moreover, p35 phosphorylation at Ser-8 and Thr-138
sites by Cdk5 suppresses its calpain-catalyzed truncation, but
increases its F-actin bundling and binding activities, which in
turn would stabilize actin filaments (Kamei et al., 2007; He et al.,
2011).
We previously demonstrated a transient increase of
p25 expression in the synaptosomal fraction of rat striatum
after acute amphetamine treatment (Mlewski et al., 2008).
These enhanced p25 levels were associated with a significant
rise in Cdk5 activity and an enrichment of p21-activated
kinase 1 (PAK1) phosphorylated on Thr-212, the specific site
for Cdk5 kinase (Mlewski et al., 2008). PAK1 is involved in
actin remodeling, dendritic spine morphogenesis, excitatory
synapse formation, and synaptic plasticity (Zhang, 2005). It
has been suggested that Cdk5 allows PAK1 to switch from an
active to an inactive state and thereby mediate a rapid and
dynamic regulation of the actin cytoskeleton (Rashid et al.,
2001), thus facilitating dendritic spine formation. Altogether,
these observations support the model that p25-regulated
Cdk5 activity is specifically involved in cellular events underlying
psychostimulant-induced synaptic plasticity.
Considering that calpain-mediated cleavage of p35 is the only
way to generate p25 (Kusakawa et al., 2000; Kerokoski et al.,
2004; Zhu et al., 2011), and that cocaine and amphetamine
increase intracellular Ca2+ levels, we next tested whether the
amphetamine effect on dendritic spine density in hippocampal
neurons requires calpain activity. Calpains are a family of
cysteine, non-lysosomal, calcium-dependent proteases whose
substrates are involved in signal transduction, cytoskeleton
remodeling, cell differentiation, vesicular trafficking, axonal
degeneration and neuronal death (Liu J. et al., 2008). A
unique feature of this protease is that its processed substrates
often acquire different functions (Ma, 2013). An example
of this is p35, which is cleaved to p25 by calpain. The
resultant Cdk5/p25 complex exerts several functions associated
to corticogenesis, cytoskeleton dynamic, synaptic plasticity, and
dendritic spine formation (Kerokoski et al., 2004; Fischer et al.,
2005; Mlewski et al., 2008; Barnett and Bibb, 2011; Lai et al.,
2012). Considering that Ca2+-dependent processes are fast and
transient, we first determined the time course of amphetamine’s
effect on dendritic spine density in hippocampal cultures.
Sixty minutes of amphetamine exposure were sufficient to
significantly increase dendritic spine density, suggesting rapid
post-translational modification of specific proteins, such as
calpain and its substrates. Consistently, strong calpain proteolytic
activity was detected in amphetamine-treated cultures, and
pharmacological inhibition prevented the increase in dendritic
spine density in hippocampal CA1 pyramidal neurons exposed
to amphetamine. In line with these observations, conditional
deletion of calpain-1 and calpain-2 results in lower dendritic
spine density in the apical and basal dendrites of hippocampal
CA1 pyramidal neurons (Amini et al., 2013). Interestingly,
calpain inhibition also prevented the amphetamine-induced
increase in the densities of mushroom and thin spines types,
precisely the same dendritic spines types that are increased
by amphetamine in p25-overexpressing neurons. Initially it
was thought that spine synapses originate from established
synapses first on the dendritic shaft by the enlargement and
then by narrowing of the neck and the emergence of the
spine head (Miller and Peters, 1981). Otherwise, filopodia
have been considered as precursors of mature dendritic
spines. Considering that most of spines have a presynaptic
partner (Gray, 1959; Harris and Kater, 1994), it has been
suggested that dendritic filopodia search for presynaptic axon
terminals to form synapses, giving rise to more developed
spines after the first contact (Jontes and Smith, 2000; Yuste
and Bonhoeffer, 2004). Furthermore, time-lapse experiments
in hippocampal slices maintained in culture, subsequently
demonstrated that filopodia are highly dynamic structures,
extending and retracting in short time periods (Dailey and
Smith, 1996). Besides, it has been shown that filopodia
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from cultured neurons establish contact with axons, and its
number decreased in correlation with the increase in spines
number (Ziv and Smith, 1996). Thus, the initial contact
with axons triggers the formation of spines from filopodia.
Finally, in vivo imaging of dendritic spines in the neocortex
of developing and adult animals from multiphoton microscopy
supports the fact that spines constantly form by seeking
out presynaptic partners in the surrounding neuropil and
stabilizing into functional spines of varied morphology, a
process driven by sensory experience (Lendvai et al., 2000;
Trachtenberg et al., 2002; Holtmaat et al., 2005; Knott et al.,
2006).
In summary, we demonstrate that amphetamine increases
dendritic spine density in hippocampal neurons through the
proteolytic cleavage of p35 into p25 by calpain, which in
turn results in p25-depedent activation of Cdk5. p25-activated
Cdk5 likely endows different properties to Cdk5, resulting
in different roles at discrete levels of organization and
different regulatory strategies in the recognition of particular
substrates. The apparent lack of p25 in naïve conditions,
together with its ability to enhance synaptic plasticity, suggests
that it is shaped only during particular events, such as
during learning (Fischer et al., 2005) or exposure to drugs
of abuse (Mlewski et al., 2008). It is possible that in turn,
the Cdk5/p25 complex could modulate critical substrates
involved in the reorganization and dynamics of the actin
cytoskeleton (Dietz et al., 2012), a fundamental mechanism
in the formation of dendritic spines and the excitatory
synapses they are part of. Revealing the cellular and synaptic
mechanisms underlying drug addiction and the identification
of the molecules involved will yield novel opportunities of
potential therapeutic targets for the treatment of addictive
disorders.
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